Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014 Aug;11(8):506-14. doi: 10.1038/nrgastro.2014.66. Epub 2014 Jun 10. PMID: 24912386.
BIOCODEX. Saccharomyces boulardii CNCM I-745® - Company Core Data Sheet. 2021. Reference: I.2963/EN.
McFarland, LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World journal of gastroenterology: WJG. 2010; 16(18): 2202.
Pais P, Almeida V, Yılmaz M, Teixeira MC. Saccharomyces boulardii: What Makes It Tick as Successful Probiotic? J Fungi (Basel). 2020 Jun 4;6(2):78. doi: 10.3390/jof6020078.
Kabbani et al. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers. Gut Microbes. 2017 Jan 2;8(1):17-32. doi: 10.1080/19490976.2016.1267890.
Chen Y, Zhou J, Wang L. Role and Mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol. 2021;11:625913. Published 2021 Mar 17. doi:10.3389/fcimb.2021.625913
Weiss GA, Hennet T. Cell Mol Life Sci. 2017 Aug;74(16):2959- 2977. doi: 10.1007/s00018-017-2509-x
Hrncir T. Gut Microbiota Dysbiosis: Microorganisms. 2022 Mar 7;10(3):578. doi: 10.3390/microorganisms10030578
Queen J, Zhang J, Sears CL. Oral antibiotic use and chronic disease: Gut Microbes. 2020;11(4):1092-1103. doi:10.1080/19490976.2019.1706425